PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 1943731-4 1991 With norgestrel administration, HTGL activity increased from 79 +/- 19 to 109 +/- 24 nmol/min/mL (P less than .05); HDL cholesterol decreased from 64 +/- 17 to 43 +/- 7 mg/dL (P less than .05); HDL2 cholesterol decreased from 21 +/- 17 to 6 +/- 5 mg/dL (P less than .05); and HDL3 cholesterol concentration decreased from 43 +/- 8 to 38 +/- 8 mg/dL (P less than .05). Norgestrel 5-15 junctophilin 3 Homo sapiens 194-198 3132043-3 1988 Other effects, however, were apparently dependent on the type of progestin, with the androgenically potent agent dl-norgestrel causing dramatic increases in low-density lipoprotein (LDL)-cholesterol and the ratio of low-density to high-density lipoprotein (HDL) and decreases in HDL, particularly HDL2, and apoprotein Al. Norgestrel 113-126 junctophilin 3 Homo sapiens 297-301 3132043-6 1988 In contrast to the findings of the previous study, norgestrel lowered LDL and produced less substantial decreases in HDL and HDL2. Norgestrel 51-61 junctophilin 3 Homo sapiens 125-129 6401927-6 1983 HDL2b increased with the norethindrone oral contraceptive and declined with the norgestrel oral contraceptive. Norgestrel 80-90 junctophilin 3 Homo sapiens 0-4